AI Science Tracker
EN

Optimized graph neural network-multilayer perceptron fusion classifier for metastatic prostate cancer detection in Western and Asian populations.

Affiliation not stated in the reviewed material · 28 Jan 2025 · medicine

Discovery

Optimized graph neural network-multilayer perceptron fusion classifier for metastatic prostate cancer detection in Western and Asian populations.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Reactome-constrained GNN P-NETwa with downstream MLP and DeepLIFT attribution selects features and predicts metastatic prostate cancer. 18-gene panel accuracy/F1 .88/.75 internal test and .87/.85 external validation; selected genes are predictive signatures, not proven causal drivers. 1,360 development samples split 80/10/10 and two independent external datasets; retrospective public cohorts and Asian subgroup imbalance constrain use.

Technology: Reactome-constrained GNN P-NETwa with downstream MLP and DeepLIFT attribution selects features and predicts metastatic prostate cancer.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Reactome-constrained GNN P-NETwa with downstream MLP and DeepLIFT attribution selects features and predicts metastatic prostate cancer.
Limitation / still unknown
Both validations use retrospective public cohorts, with subgroup imbalance; the predictive gene panel does not establish causal drivers or prospective clinical utility.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12490683/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.